USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'c2a and ngs'
- Related search terms
- NGS Informatics Market Forecast to 2027
- AND 5433=7320
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
-
30 Jun 2023 | Global | Market Research
Next-generation Sequencing Informatics, Forecast to 2027
Development of Genomics and Precision Medicine Supported by Artificial Intelligence and Cloud Computing to Transform the Field
With the democratization of next-generation sequencing (NGS) technology and continual decline in sequencing costs, its application areas have expanded, leading to increased demand for NGS informatics solutions in different environments. The advances in NGS technology are leading to market growth and will likely boost its demand with the incorporati...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 May 2022 | North America | Market Research
Global NGS Library Preparation Growth Opportunities
Intelligent and Accessible Laboratory Automation is the Cornerstone to Transform Research, Improve Library Quality, and Achieve Consistent Yield
NGS library preparation incorporates processing steps that convert genomic DNA or RNA into an appropriate format for the selected sequencing technology. The workflow starts with isolating nucleic acids, fragmented, end-repaired, and connected to adapters using methods like ligation or tagmentation. Sequencing applications incorporate whole genome, ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2024 | Global | Market Research
Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030
Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development
This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...
$4,950.00
Special Price $4,207.50 save 15 %
-
03 Feb 2021 | North America | Market Research
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Apr 2016 | Global | Market Research
Global Life Science Instrumentation Market, Forecast to 2020
Innovative Next-generation Sequencing (NGS) Technology to Fuel Growth
The global life science instrumentation market recorded revenue of $4.05 billion in 2015; it is expected to grow at a Cumulative Annual Growth Rate (CAGR) of 7.6% from 2015 to 2020. Next-generation Sequencing (NGS) instruments has outpaced other research instruments due to reduced sequencing costs. Thermo Fisher Scientific, Agilent Technologies, an...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Dec 2023 | Global | Technology Research
Advancements in Next-gen Sequencing and Genomic Analysis
NGS Platforms and Genomic Analysis to Ensure Transformational Growth of Precision Medicine
Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 May 2026 | Global | Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00 -
11 Jun 2014 | Global | Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2017 | Europe | Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
08 Nov 2016 | North America | Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %
